Raymond Scott Turner, MD, PhD

Affiliations: 
1979-1984 Pharmacology Emory University, Atlanta, GA 
 1984-1988 Medicine Emory University, Atlanta, GA 
 1988-1989 Medicine University of Pennsylvania, Philadelphia, PA, United States 
 1989-1995 Neurology University of Pennsylvania, Philadelphia, PA, United States 
 1995-2008 Neurology University of Michigan, Ann Arbor, Ann Arbor, MI 
 2008- Neurology Georgetown University, Washington, DC 
Area:
Alzheimer's disease
Website:
http://memory.georgetown.edu
Google:
"Raymond Scott Turner"
Bio:

The mission of the Georgetown University Memory Disorders Program is to prevent and treat Alzheimer's disease and related dementias by conducting innovative research, educating and training healthcare professionals and the public on research advances, and offering state-of-the-art clinical care.

Mean distance: 14.18 (cluster 24)
 
SNBCP
Cross-listing: Alzheimer's Tree

Parents

Sign in to add mentor
J.-F. Kuo grad student 1979-1985 Emory
Murray Grossman post-doc 1992-1995 Georgetown
Virginia Man-Yee Lee post-doc 1992-1995 Penn
John Q. Trojanowski post-doc 1992-1995 Penn
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sacktor N, Soldan A, Grega M, et al. (2017) The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders
Lee NJ, Song JM, Cho HJ, et al. (2015) Hexa (ethylene glycol) derivative of benzothiazole aniline promotes dendritic spine formation through the RasGRF1-ras dependent pathway. Biochimica Et Biophysica Acta
Turner RS, Thomas RG, Craft S, et al. (2015) A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology
Lonskaya I, Hebron ML, Selby ST, et al. (2015) Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer's disease models. Neuroscience. 304: 316-27
Mandelblatt JS, Stern RA, Luta G, et al. (2014) Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1909-18
Song JM, DiBattista AM, Sung YM, et al. (2014) A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease. Experimental Neurology. 252: 105-13
Song JM, DiBattista AM, Sung YM, et al. (2014) Corrigendum to "A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease" [Exp. Neurol. 252 (2014) 105-113] Experimental Neurology. 261: 541-542
Albert M, Soldan A, Gottesman R, et al. (2014) Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to apoe genotype Current Alzheimer Research. 11: 773-784
Kreisl WC, Lyoo CH, McGwier M, et al. (2013) In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. Brain : a Journal of Neurology. 136: 2228-38
Megill A, Lee T, DiBattista AM, et al. (2013) A tetra(ethylene glycol) derivative of benzothiazole aniline enhances Ras-mediated spinogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 9306-18
See more...